Prognosis of Prehypertension Without Progression to Hypertension.
作者信息
Niiranen Teemu J, Larson Martin G, McCabe Elizabeth L, Xanthakis Vanessa, Vasan Ramachandran S, Cheng Susan
机构信息
From National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (T.J.N., M.G.L., V.X., R.S.V., S.C.); Department of Biostatistics (M.G.L., V.X.), Department of Medicine, Section of Preventive Medicine (R.S.V.), Department of Medicine, Section of Cardiology (R.S.V.), and Department of Epidemiology (R.S.V.), Boston University School of Public Health, MA; and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (E.L.M., S.C.).
出版信息
Circulation. 2017 Sep 26;136(13):1262-1264. doi: 10.1161/CIRCULATIONAHA.117.029317.
Abstract
摘要
相似文献
1
Prognosis of Prehypertension Without Progression to Hypertension.未进展为高血压的前期高血压的预后
Circulation. 2017 Sep 26;136(13):1262-1264. doi: 10.1161/CIRCULATIONAHA.117.029317.
2
Is it time to target prehypertension.是时候将高血压前期作为目标了吗？
Cardiovasc Ther. 2010 Dec;28(6):337-8. doi: 10.1111/j.1755-5922.2010.00234.x.
3
Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012.1999 - 2012年美国成年人高血压前期和高血压危险因素的趋势
Hypertension. 2017 Aug;70(2):275-284. doi: 10.1161/HYPERTENSIONAHA.116.09004. Epub 2017 Jun 12.
4
Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.高血压前期的降压治疗与其他治疗选择：循证方法
Future Cardiol. 2012 Jan;8(1):115-22. doi: 10.2217/fca.11.83.
5
Preventing the progression of prehypertension to hypertension: role of antihypertensives.预防高血压前期进展为高血压：抗高血压药物的作用
Curr Hypertens Rep. 2015 Jan;17(1):505. doi: 10.1007/s11906-014-0505-1.
6
Prehypertension is real and can be associated with target organ damage.高血压前期是真实存在的，并且可能与靶器官损害相关。
J Am Soc Hypertens. 2017 Nov;11(11):704-708. doi: 10.1016/j.jash.2017.09.005. Epub 2017 Sep 21.
7
Prehypertension: the rationale for early drug therapy.高血压前期：早期药物治疗的原理。
Cardiovasc Ther. 2010 Dec;28(6):339-43. doi: 10.1111/j.1755-5922.2010.00167.x.
8
National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults.越南成年人中高血压和高血压前期的全国患病率及相关危险因素。
Am J Hypertens. 2015 Jan;28(1):89-97. doi: 10.1093/ajh/hpu092. Epub 2014 May 26.
9
Treatment of prehypertension: lifestyle and/or medication.高血压前期的治疗：生活方式和/或药物治疗。
Vasc Health Risk Manag. 2012;8:613-9. doi: 10.2147/VHRM.S29138. Epub 2012 Nov 15.
10
Exercise capacity and progression from prehypertension to hypertension.运动能力与高血压前期进展为高血压。
Hypertension. 2012 Aug;60(2):333-8. doi: 10.1161/HYPERTENSIONAHA.112.196493. Epub 2012 Jul 2.
引用本文的文献
1
Derivatives of the triglyceride-glucose index and their association with incident hypertension in prehypertensive individuals: a 4-year cohort study augmented by mendelian randomization.甘油三酯-葡萄糖指数衍生物及其与高血压前期个体新发高血压的关联：一项通过孟德尔随机化增强的4年队列研究。
Cardiovasc Diabetol. 2025 Jul 11;24(1):284. doi: 10.1186/s12933-025-02813-6.
2
Blood pressure in young Aboriginal and Torres Strait Islander people: analysis of baseline data from a prospective cohort study.年轻原住民和托雷斯海峡岛民的血压：一项前瞻性队列研究的基线数据分析
Med J Aust. 2025 Feb 3;222(2):91-101. doi: 10.5694/mja2.52558. Epub 2024 Dec 11.
3
Modifiable lifestyle factors in the primordial prevention of hypertension in three US cohorts.美国三个队列中高血压一级预防的可改变生活方式因素
Eur J Intern Med. 2025 Feb;132:55-66. doi: 10.1016/j.ejim.2024.10.028. Epub 2024 Nov 6.
4
Effects of Casein-Derived Peptide Met-Lys-Pro on Systolic and Diastolic Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.酪蛋白衍生肽 Met-Lys-Pro 对收缩压和舒张压的影响：一项随机、双盲、安慰剂对照、平行组研究。
Nutrients. 2024 Sep 3;16(17):2975. doi: 10.3390/nu16172975.
5
Prevalence of modifiable risk factors for cardiovascular disease among school-going children and adolescents in Eldoret, Kenya.肯尼亚埃尔多雷特地区在校儿童和青少年心血管疾病可改变风险因素的流行情况。
Pan Afr Med J. 2024 Mar 4;47:100. doi: 10.11604/pamj.2024.47.100.42340. eCollection 2024.
6
Sex-specific and polygenic effects underlying resting heart rate and associated risk of cardiovascular disease.静息心率的性别特异性和多基因效应及其与心血管疾病风险的关联。
Eur J Prev Cardiol. 2024 Sep 20;31(13):1585-1594. doi: 10.1093/eurjpc/zwae092.
7
Early-onset alcohol, tobacco, and illicit drug use with age at onset of hypertension: a survival analysis.早发性酒精、烟草和非法药物使用与高血压发病年龄的关系：一项生存分析。
Soc Psychiatry Psychiatr Epidemiol. 2024 Jul;59(7):1129-1141. doi: 10.1007/s00127-023-02596-9. Epub 2023 Dec 16.
8
Effect of fixed 7.5 minutes' moderate intensity exercise bouts on body composition and blood pressure among sedentary adults with prehypertension in Western-Kenya.在肯尼亚西部患有高血压前期的久坐不动成年人中，固定时长7.5分钟的中等强度运动对身体成分和血压的影响。
PLOS Glob Public Health. 2022 Jul 21;2(7):e0000806. doi: 10.1371/journal.pgph.0000806. eCollection 2022.
9
Ischemic Conditioning Ameliorated Hypertension and Vascular Remodeling of Spontaneously Hypertensive Rat via Inflammatory Regulation.缺血预处理通过炎症调节改善自发性高血压大鼠的高血压和血管重塑。
Aging Dis. 2021 Feb 1;12(1):116-131. doi: 10.14336/AD.2020.0320. eCollection 2021 Feb.
10
Age of Hypertension Onset: Overview of Research and How to Apply in Practice.高血压发病年龄：研究概述及在实践中的应用。
Curr Hypertens Rep. 2020 Aug 27;22(9):68. doi: 10.1007/s11906-020-01071-z.
本文引用的文献
1
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.队列简介：弗雷明汉心脏研究（FHS）：心血管流行病学里程碑概述。
Int J Epidemiol. 2015 Dec;44(6):1800-13. doi: 10.1093/ije/dyv337.
2
Prehypertension--prevalence, health risks, and management strategies.高血压前期——患病率、健康风险和管理策略。
Nat Rev Cardiol. 2015 May;12(5):289-300. doi: 10.1038/nrcardio.2015.17. Epub 2015 Feb 17.
3
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension.社区高血压管理临床实践指南：美国高血压学会和国际高血压学会声明
J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26. doi: 10.1111/jch.12237. Epub 2013 Dec 17.
4
Impact of high-normal blood pressure on the risk of cardiovascular disease.血压略高于正常范围对心血管疾病风险的影响。
N Engl J Med. 2001 Nov 1;345(18):1291-7. doi: 10.1056/NEJMoa003417.
5
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study.弗雷明汉心脏研究中未患高血压参与者进展为高血压的频率评估：一项队列研究。
Lancet. 2001 Nov 17;358(9294):1682-6. doi: 10.1016/S0140-6736(01)06710-1.
Zotero 插件